TrialBlood advances2025

Point-of-care fresh CAR T cells for pediatric or young adult BCP-ALL that is relapsed/refractory or in very-high-risk first relapse.

Francesca Del Bufalo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.